IGF2BP3 and lung carcinoma: After its initial identification, IGF2BP3 was found to be a mainly overexpressed member of its protein family in various tumor types, such as squamous cell carcinoma [27], lung cancer [28], melanoma [29], colon cancer [30] and liver cancer [31].